Company Overview and News
Exxon Mobil Corporation (XOM - Free Report) recently disclosed its intention to import liquefied natural gas (LNG) through the east coast of Australia. The largest publicly traded energy company is one of the leading gas suppliers in the southeastern part of Australia and the move is expected to retain its hold in the market, while staying ahead of competitors. The primary reason for the import is gas shortage, which is anticipated to hit the market in 2021.
HD BLT XOM BHPBF AGLNF AGLNY DK BHP HFC BBL MARUF BHP BHPLF
Amazon founder and CEO Jeff Bezos, the wealthiest person in the world, is richer than he has ever been before. Since June 1, the tech titan's net worth has grown over $5 billion and now totals $141.9 billion, according to the Forbes World's Billionaires list. That makes Bezos worth roughly $49 billion more than Bill Gates and about $60 billion more than Warren Buffett.
Rowan (RDC) has just announced that its jack-up Bob Palmer has been leased to ARO Drilling for a three-year contract with Saudi Aramco. The rig has previously been working in Saudi Arabia and will continue doing so through ARO Drilling.
As the kingdom prepares for its next evolution, Saudi Aramco is central. But a planned public listing leaves the company, and the country, at risk.
RDS.B RDS.A XOM RYDBF DOW RDSB NYTAB RDSA RYDAF
Petrobras – Petroleo Brasileiro S.A. (PBR) (NYSE:PBR) has been so volatile it might make investors sick. Some might be asking whether they’re riding a roller coaster or are long on PBR stock.
UPS XOM PXD FDX GOOG PBR EOG COP X GOOGL CVX OIH
The state government has committed to a redress scheme for those who have fallen ill or died after being exposed to toxic chemicals at the former Fiskville CFA training college.
The week started strong, with MLPs up 1.6% Monday, but then followed up with 4 straight negative days, culminating in a big Friday selloff (-2.6%). Friday was the MLP Index's worst day since March 19th, just a few days after the FERC ruling. It was also the worst week for the index since that same week in March. Unlike that week, there wasn't any big midstream news that led to the drop. The action this week was more related to the macro (i.
ETP.PRC CQP DCP XOM PSX PAGP ENB WGP CEQP AM USAC WMB AMGP PAA D CNXM ENB SRE.PRA TCP ETP SRE DM NRP TRGP
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning.
NPSNY SYY RUTH LX MS DECK SRRK EQIX JACK MDT TACOW KNSA VZ ZOES FB CLPS QNST MCRI KR SMTC CCL RYDAF EVOP INTC DRRX ICLK MUSA ITUB BB UNFI RHT PTIE HLF JPM MU FNKO HBNC SBUX LOCO PLAY XOM TWX MS.PRE MS.PRF MS.PRG RDSB TOT RDSA MS.PRA SHAK HMNY SAFM BKS AAN OSTK GSKY INCY CTLR CCL BP MS.PRI GOOGL MS.PRK FLL RYDBF MKSI FITB CLR BB PPC BC NDLS DOGZ FND DRI SGBXQ FINL WGO COP XHR DAL ORCL DIS JASO F RDS.B RDS.A TACO DISH TMSR SPTN FDX VLO GOLF CHUY SNY CHEF W ITRM SGBX CVX SNE
BARILOCHE, Argentina, June 15 (Reuters) - Uruguay will move toward a permanent offer process for offshore oil blocks as other Latin American countries have done, after an April auction failed to attract bids, Industry, Energy and Mining Minister Carolina Cosse said in an interview this week.
RDS.B RDS.A XOM BP RDSB RDSA GLPEF BP.A BP.B BP RYDBF TLW BPAQF RYDAF GLPEY
The Dow traversed a tough week, suffering losses for three consecutive sessions. Initially, investors were wary of the outcomes of the Fed and ECB meetings. The outcome of the meeting between President Trump and North Korea’s Kim Jong Un was also eagerly awaited.
CATR SPG.PRJ JNJ CAT XOM BOE VZ SPG BA DIS VZA
EnLink Midstream Partners, LP (NYSE:ENLK) has 157 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 159,438,371 shares. Largest shareholders include Brookfield Asset Management Inc., Center Coast Capital Advisors, LP, Alps Advisors Inc, Oppenheimer Funds Inc, Clearbridge Investments, LLC, Advisory Research Inc, Harvest Fund Advisors LLC, Tortoise Capital Advisors, L.
BAMGF PRTO XOM ENLK DVN GALPW GALE BAMKF STML BAM ENLC GALEW
Enlink Midstream, LLC (NYSE:ENLC) has 139 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 61,014,489 shares. Largest shareholders include Chickasaw Capital Management Llc, Tortoise Capital Advisors, L.l.c., Salient Capital Advisors, LLC, Advisory Research Inc, Dimensional Fund Advisors Lp, RR Advisors, LLC, Cushing Asset Management, Lp, Lsp Investment Advisors, Llc, Lubar & Co.
PRTO XOM ENLK DVN GALPW GALE STML ENLC GALEW
2018-06-18 - Asif
Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...
2018-06-11 - Asif
Overview Proteon Therapeutics is a late-stage biopharmaceutical company focused on the development of novel, first-in-class pharmaceuticals to address the needs of patients with renal and vascular disease. The company's product candidate, vonapanitase, is a recombinant human elastase that Proteon Therapeutics is developing to improve vascular access outcomes in patients with chronic kidney disease, or CKD, undergoing or planning for hemodialysis, a lifesaving treatment that cannot be conducted without a functioning vascular access. The company believe data from its completed Phase 2 and Phase 3 clinical trials of vonapanitase support that a one-time, local application of investigational vonapanitase during surgical creation of a radiocephalic fistula for hemodialysis may improve fistula use for hemodialysis and secondary patency (time to fistula abandonment), thereby improving patient outcomes and reducing the burden on patients and the healthcare system. Arteriovenous fistu...
2018-06-11 - Asif
Overview Galena Biopharma is a clinical-stage biopharmaceutical company focused on novel cancer immunotherapeutics for a broad range of cancer indications. The company's lead product candidate, galinpepimut-S, or GPS, is a cancer i unotherapeutic agent licensed from Memorial Sloan Kettering Cancer Center, or MSK, that targets the Wilms tumor 1, or WT1, protein, which is present in 20 or more cancer types. Based on its mechanism of action as a directly immunizing agent, GPS has the potential as a monotherapy or in combination with other immunotherapeutic agents to address a broad spectrum of hematologic, or blood, cancers and solid tumor indications. Phase 2 clinical trials for GPS have been completed and Galena Biopharma has planned Phase 3 clinical trials (pending funding availability) for two indications, acute myeloid leukemia, or AML, and malignant pleural mesothelioma, or MPM. GPS is also in development as a potential treatment for multiple myeloma, or MM, and ovarian can...
Silicon Investor Message Boards
This table lists all message boards related to XOM / Exxon Mobil Corp. on message board site Silicon Investor.
|Exxon Mobil (XOM)||XOMA. Bull or Bear?|
|XON - Exxon Corp.||12-STEP XOMA-HOLIC RECOVERY THREAD|
|xoma||XOMED (XOMD) Have a look .|
|HOT STOCKS (ADI WCOM ASND VLSI PMCS XOMA PAIR)|
as of ET